The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Nafcillin
Nafcillin Sodium · NAFCILLIN SODIUM 2 g/8mL · Injection, Powder, For Solution · Intramuscular; Intravenous · NorthStar Rx, LLC
NDC 72603-0453-01 · 1 VIAL in 1 BOX / 8 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $617.70 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA090002
- TE code
- AP
- Approval date
- Jun 30, 2011
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Nafcillin Sodium (Injection, Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Eugia US LLC | NAFCILLIN SODIUM 2 g/8mL | Jul 15, 2026 | Sep 3, 2026 |
| Armas Pharmaceuticals Inc. | NAFCILLIN SODIUM 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Armas Pharmaceuticals Inc. | NAFCILLIN SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Avenacy Inc. | NAFCILLIN SODIUM 10 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | NAFCILLIN SODIUM 1 g/4mL | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc. | NAFCILLIN SODIUM 1 g/4mL | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc. | NAFCILLIN SODIUM 2 g/8mL | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar Rx, LLC | NAFCILLIN SODIUM 2 g/8mL | Jul 15, 2026 | Sep 2, 2026 |
| Onesource Specialty Pharma Limited | NAFCILLIN SODIUM 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Onesource Specialty Pharma Limited | NAFCILLIN SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | NAFCILLIN SODIUM 10 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | NAFCILLIN SODIUM 10 g/100mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Nafcillin — NDC 72603-0453-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72603045301.
Free to cite with attribution — see how the data is put together.